The anticancer medicine imatinib mesylate was synthesized through condensation, reduction and cyclization reaction using 4-methyl-3-nitroaniline as raw material.The advantages of using anhydrous potassium carbonate instead of diisopropylethylamine, replacing Pt/C catalyst with hydrazine hydrate and common catalyst, using isopentyl alc. as solvent were discussed, resp.Finally, the total yield was over 50% and purity of product was over 99.5% identified by HPLC.